newsfilter
← Latest News
GlobeNewswire·

Oculis Reports Q1 2026 Financial Results and Provides Company Update

Pipeline Advancing as Planned, Leading with OCS-01 Key Milestone Completion of LPLV in Both DIAMOND Phase 3 Trials; Data Readout on Track for June 2026Licaminlimab PREDICT-1 Trial in Active Site Recruitment Phase,